As of the latest SEC filings, Taysha Gene Therapies, Inc. (TSHA) is held by 156 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $33,587,356.50 in market value, representing a significant portion of its portfolio.
Funds holding Taysha Gene Therapies, Inc. (TSHA)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- TSHA
- CIK:
- 0001806310
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $33,587,356.50 | 7,513,950 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.34% | $25,205,932.17 | 5,638,911 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.03% | $24,187,165.53 | 5,410,999 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.02% | $18,917,746.59 | 4,176,103 | Feb 28, 2026 | Apr 24, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.04% | $13,957,938.99 | 2,184,341 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $11,080,781.34 | 2,478,922 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.07% | $8,018,755.35 | 1,793,905 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.09% | $7,474,644.60 | 1,672,180 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.03% | $6,291,345.54 | 1,388,818 | Feb 28, 2026 | Apr 24, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.32% | $6,005,322.00 | 939,800 | Apr 30, 2026 | Jun 26, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $5,237,055.99 | 1,156,083 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.03% | $4,957,980.81 | 1,094,477 | Feb 28, 2026 | Apr 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.02% | $4,843,208.73 | 1,069,141 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.81% | $4,564,151.61 | 1,021,063 | Mar 31, 2026 | May 29, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.08% | $4,260,356.28 | 940,476 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.02% | $3,967,464.60 | 875,820 | Feb 28, 2026 | Apr 24, 2026 |
|
FYC
First Trust Small Cap Growth AlphaDEX Fund
|
ETF | First Trust | 0.32% | $3,338,653.59 | 522,481 | Apr 30, 2026 | Jun 23, 2026 |
|
FESM
Fidelity Enhanced Small Cap ETF
|
ETF | Fidelity | 0.08% | $3,259,886.07 | 729,281 | Mar 31, 2026 | May 26, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.04% | $3,085,986.60 | 482,940 | Apr 30, 2026 | Jun 25, 2026 |
|
KOMP
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF
|
ETF | State Street (SPDR) | 0.11% | $2,676,452.73 | 598,759 | Mar 31, 2026 | May 28, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.20% | $2,487,782.97 | 556,551 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.01% | $2,394,479.97 | 374,723 | Apr 30, 2026 | Jun 26, 2026 |
|
USCAX
Victory Small Cap Stock Fund
|
MF | Independent / Boutique | 0.25% | $2,287,754.19 | 358,021 | Apr 30, 2026 | Jun 25, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 0.40% | $2,062,634.49 | 322,791 | Apr 30, 2026 | Jun 29, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,869,888.87 | 412,779 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)